GalNAc
UDP-GalNAc.2Na
Quick view. We supply UDP-GalNAc.2Na for glycochemistry and carbohydrate research. The released purity specification and lot documentation are confirmed with our technical team before order. CAS 108320-87-2. Catalog target purity: Specification on request.
Product profile
UDP-GalNAc.2Na is classified as nucleoside diphosphate or analog (Formula C17H25N3Na2O17P2; molecular weight 651.32).
UDP-GalNAc.2Na can support enzyme-substrate, in-vitro transcription, polymerase-screening or analytical-reference studies as appropriate to its phosphate state.
For UDP-GalNAc.2Na, reported solubility: H₂O: 50 mg/mL, clear, colorless. Storage: -20°C.
Names and search terms
Confirmed or normalized name variants
- PUBCHEM_16220073
- UDP-N-acetylgalactosamine
- URIDINE-5'-DIPHOSPHO-N-ACETYL-GALACTOS-&
- UDP-N-acetyl-D-galactosamine disodium salt
- Uridine 5′-diphospho-N-acetylgalactosamine
- UDP-a-D-N-Acetylgalactosamine,Disodium Salt
- UDP-α-D-N-Acetylgalactosamine, Disodium Salt
- UDP-ALPHA-D-N-ACETYLGALACTOSAMINE, DISODIUM SALT
Useful catalog search terms
- CAS 108320-87-2
- Nucleoside diphosphate or analog
- GalNAc ligand motif
- GalNAc
Physicochemical data
| Key chemistry motifs | GalNAc ligand motif |
|---|---|
| InChI | InChI=1/C17H27N3O17P2.Na.H/c1-6(22)18-10-13(26)11(24)7(4-21)35-16(10)36-39(31,32)37-38(29,30)33-5-8-12(25)14(27)15(34-8)20-3-2-9(23)19-17(20)28;;/h2-3,7-8,10-16,21,24-27H,4-5H2,1H3,(H,18,22)(H,29,30)(H,31,32)(H,19,23,28);;/t7-,8-,10-,11+,12-,13-,14-,15-,16-;;/s |
| InChIKey | BREKHDYLBRBJNL-GCYTWECPNA-N |
| SMILES | O[C@@H]1[C@@H]([C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(=O)C)O[C@H]1N1C=CC(=O)NC1=O)O.[NaH] |&1:1,2,3,14,16,19,21,23,29,r| |
| Form | White solid |
| Color | White to off-white |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical qualification includes identity, salt/counterion, assay basis, water content and enzyme compatibility.
- Related uses include LC-MS/HPLC method development and comparison with native or modified nucleotide controls.
Product-specific evaluation notes
Potential advantages
- A defined GalNAc intermediate helps decouple ligand-linker optimization from sequence optimization.
Method limitations
- In-vitro affinity and in-vivo delivery behavior may diverge; valency, linker length and conjugation site need empirical confirmation.
These points describe UDP-GalNAc.2Na or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
(6R)-FR054
GalNAc · CAS: 10378-06-0
BX-GALN-0002AdemA-GalNAc Phosphoramidite
GalNAc · CAS: 1953147-02-8
BX-GALN-0003AdemC-GalNAc Phosphoramidite
GalNAc · CAS: N/A
BX-GALN-0004GalNAc PEG Cluster Phosphoramidite
GalNAc · CAS: N/A
BX-GALN-0005GalNAc-L96 Linker-Acid
GalNAc · CAS: 1426159-34-3
BX-GALN-0006GalNAc-L96 Linker-Azide
GalNAc · CAS: 2135330-72-0
Frequently asked questions
Can the package size for UDP-GalNAc.2Na be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-GALN-0044 and CAS 108320-87-2, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the GalNAc product family and its named chemistry.